Brilliant Acquisition Corporation (BRLI)

NEW YORK--(BUSINESS WIRE)---- $BRLI #Fintech--Nukkleus Inc. (NASDAQ: NUKK), a pioneering force in the fintech industry, is excited to announce that it has signed a term sheet for the acquisition of Mercury Global, a leading cross-border payments firm with operations in London and South Africa. This significant step marks Nukkleus' strategic move to further strengthen its presence in the dynamic world of cross-border payments. Under the proposed agreement, Nukkleus is set to acquire the entire issued share capital.

NEW YORK , Nov. 30, 2023 /PRNewswire/ -- Nukkleus, Inc. (formerly Compliance & Risk Management Solutions Inc.) (OTC: NUKK) proudly announces the completion of its strategic merger with Brilliant Acquisition Corp (Nasdaq: BRLI), marking a significant milestone in the financial technology landscape. This merger, valuing Nukkleus at around $105 million, signifies a bold step into a future rich with digital asset opportunities for businesses and investors alike.

New York, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until December 23, 2023. In connection with the extension, Brilliant's Sponsor, Nisun Investment Holding Limited, and Nukkleus Inc. (“Nukkleus”) deposited an aggregate of $32,300 in Brilliant's trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant's shareholders on July 20, 2023.

New York, Sept. 22, 2023 (GLOBE NEWSWIRE) --  Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until October 23, 2023. In connection with the extension, Nukkleus Inc. (“Nukkleus”) deposited $32,300 in Brilliant's trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant's shareholders on July 20, 2023. The shareholder approval also permits Brilliant to further extend Brilliant's initial business combination deadline on a monthly basis up to a further two months, or until December 23, 2023, upon deposit of an additional $32,300 in the trust account for each month.

New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until September 23, 2023. In connection with the extension, Brilliant's Sponsor, Nisun Investment Holding Limited, and Nukkleus Inc. (“Nukkleus”) deposited an aggregate of $32,300 in Brilliant's trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant's shareholders on July 20, 2023. The shareholder approval also permits Brilliant to further extend Brilliant's initial business combination deadline on a monthly basis up to a further three months, or until December 23, 2023, upon deposit of an additional $32,300 in the trust account for each month.

New York, July 21, 2023 (GLOBE NEWSWIRE) --  Brilliant Acquisition Corporation (“Brilliant”) announced today that it has extended the period of time it will have to consummate its initial business combination by a further one month, or until August 23, 2023. In connection with the extension, Nukkleus, Inc. (“Nukkleus”) has deposited $32,300 in Brilliant's trust account, representing $0.08 per public ordinary share of Brilliant currently outstanding, as additional interest on the proceeds in the trust account. The extension was approved by Brilliant's shareholders on July 20, 2023. The shareholder approval also permits Brilliant to further extend Brilliant's initial business combination deadline on a monthly basis up to a further four months, or until December 23, 2023, upon deposit of an additional $32,300 in the trust account for each month.

Nukkleus, which works on acquiring and scaling high-potential blockchain, digital and multi-asset businesses for retail and institutional markets, has debuted its new website and brand, which will put the firm's subsidiary brands under the same suite of assets, a press release said. This comes as the company has proposed to combine with Brilliant Acquisition Corp., […]

Opko Health (NASDAQ:OPK)‘s stock had its “buy” rating reissued by equities research analysts at Piper Sandler in a research report issued to clients and investors on Wednesday, TipRanks reports. They presently have a $3.00 target price on the biotechnology company’s stock. Piper Sandler’s price target indicates a potential upside of 33.33% from the stock’s current […]

Hospitals, clinics and point-of care medical centers across the country continue to grapple with critical shortages in testing supplies, more than a dozen lab personnel, state officials and medical associations say

Opko Health Inc. (NASDAQ:OPK) has been given a consensus rating of “Buy” by the six brokerages that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued a report on the stock in the last […]

Opko Health (NASDAQ:OPK) was upgraded by equities researchers at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday, BidAskClub reports. A number of other equities research analysts also recently commented on OPK. Barrington Research reiterated a “buy” rating and issued a $4.00 price objective on shares of Opko Health […]

BioReference Laboratories will provide the testing at the pharmacy chain's expanding network of drive-thru COVID-19 testing sites.

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost bought 325,000 shares of Opko Health stock in a transaction that occurred on Friday, April 17th. The shares were acquired at an average price of $1.66 per share, with a total value of $539,500.00. Following the acquisition, the chief executive officer now directly owns 3,068,951 […]

Cubist Systematic Strategies LLC cut its holdings in shares of Opko Health Inc. (NASDAQ:OPK) by 39.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,822 shares of the biotechnology company’s stock after selling 12,374 shares during the quarter. Cubist […]

Ladenburg Thalmann Financial Services Inc. reduced its position in shares of Opko Health Inc. (NASDAQ:OPK) by 8.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 122,631 shares of the biotechnology company’s stock after selling 11,993 shares during the quarter. Ladenburg Thalmann […]

Alliancebernstein L.P. increased its position in shares of Opko Health Inc. (NASDAQ:OPK) by 2.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 517,625 shares of the biotechnology company’s stock after purchasing an additional 11,600 shares during the quarter. Alliancebernstein L.P. owned approximately […]